Company intelligence
BlossomHill Therapeutics, Inc.
Addressing urgent unmet medical needs through deeper science, true originality, and rich experience...
About BlossomHill Therapeutics, Inc.
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D., and biotech business veteran, Y. Peter Li, Ph.D., M.B.A. BlossomHill Therapeutics, Inc. is headquartered in San Diego, California.
Verified activity
Signals from BlossomHill Therapeutics, Inc.
4 published signals
People
BlossomHill Therapeutics, Inc. is hiring a new Director, Regulatory Affairs in San Diego, California.
Reported by BlossomHill Therapeutics, Inc.
Capital & Finance
BlossomHill Therapeutics, Inc. was listed on the Nasdaq Exchange.
Reported by BlossomHill Therapeutics, Inc.
People
BlossomHill Therapeutics, Inc. is hiring a new Associate Director, Medical Writing in San Diego, California.
Reported by BlossomHill Therapeutics, Inc.
Presence & Recognition
BlossomHill Therapeutics, Inc. is attending the International Association for the Study of Lung Cancer 2026 World Conference on Lung Cancer in Seoul next month.
Reported by BlossomHill Therapeutics, Inc.